GlassScriptPhysician profile
Angie U Song
NPI 1982605259
$2,254.40
in general payments reported to CMS, 2019-2025
24 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $507 · 2021: $131 · 2022: $113 · 2023: $146 · 2024: $492 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831 · Travel and Lodging: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.04 |
| Travel and Lodging | $198.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $981.41 | 2019-2024 | Spy-Phi System, Aequalis Ascend Flex, Blueprint Patient Specific Instrumentation |
| Spinesmith Holdings, LLC | $240.37 | 2019 | |
| Glaxosmithkline, LLC. | $130.12 | 2023-2025 | Nucala, Shingrix, Arexvy |
| Pacira Pharmaceuticals Incorporated | $121.36 | 2025 | Exparel |
| Covidien LP | $116.07 | 2019 | |
| Inspire Medical Systems, INC. | $111.20 | 2023-2025 | Inspire |
| Amgen INC. | $71.43 | 2022-2025 | Evenity, Prolia |
| Mentor Worldwide LLC | $56.34 | 2022 | |
| Exact Sciences Corporation | $55.46 | 2023-2025 | Cologuard Collection Kit |
| Genzyme Corporation | $44.95 | 2023-2024 | |
| Baxter Healthcare | $36.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $33.33 | 2019-2025 | Dupixent |
| Fisher & Paykel Healthcare INC | $33.00 | 2025 | Fisher & Paykel Healthcare |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.66 | 2020-2023 | Spiriva Respimat, Stiolto Respimat |
| Bioventus LLC | $27.23 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $24.68 | 2022 | |
| Conmed Corporation | $23.93 | 2024 | Visiclear |
| Lilly USA, LLC | $21.60 | 2020 | |
| Merck Sharp & Dohme LLC | $16.91 | 2019 | |
| Pfizer INC. | $16.41 | 2019 | |
| Galderma Laboratories, L.P. | $16.25 | 2019 | |
| Kci USA, INC. | $14.88 | 2023 | Prevena, Activ.A.C., V.A.C. Veraflo |
| Tersera Therapeutics LLC | $14.86 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.